Johnson & Johnson

The medical devices division of Johnson & Johnson provides a wide range of products for orthopaedics, surgery, interventional therapies, and eye health. The impact of the Covid-19 epidemic on their surgical, orthopaedics, and vision businesses, as well as the resultant delays in medical operations, resulted in a 12 percent decline in medical equipment internationally. The reduction was somewhat offset by growth in the interventional solutions area, led by electrophysiology devices. In a news statement, Alex Gorsky, Chairman and Chief Executive Officer, said, "We remain very enthused about the immense potential of the end-to-end digital surgical ecosystem." "We're working on three distinct robotic projects at the same time, and our Velys Robotic-Assisted Solution, which is designed for use with the Attune Total Knee System, recently received FDA authorization." Our industry is only now realizing the full potential and benefits of robotic and digital technologies, so it's only logical that the company that pioneered sterile surgery 135 years ago is now in a position to lead the way."

In fact, the Financial Times estimates that J&J was the world's 10th-largest publicly-traded business by market valuation in the first half of the year, despite the fact that it is presently the largest maker of medical equipment globally.

It has a total revenue of about $82 billion, employs 132,200 people, and spent more than $11 billion on research and development in 2019 - the largest of any medical device company in the world.

Founded: January 1886

Headquarters: New Brunswick, New Jersey, USA

Revenue: 19,8 Billion USD

Website: https://www.jnj.com/